CoChat

Effects of Different Calcium Antagonists on Proteinuria Associated with Diabetes Mellitus

Demarie, Bryan K., Bakris, George L. · 1990 · Annals of Internal Medicine
Cited by 145

The DOI matches its Crossref record.

Abstract

Brief Reports15 December 1990Effects of Different Calcium Antagonists on Proteinuria Associated with Diabetes MellitusBryan K. Demarie, MD, George L. Bakris, MDBryan K. Demarie, MD, George L. Bakris, MDAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-113-12-987 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptStudies in various animal models of renal dysfunction show that urinary protein excretion is partly determined by glomerular capillary pressure (1-5). Further, clinical studies have shown that nifedipine, an agent that does not alter glomerular capillary pressure, increases urinary protein excretion and leads to renal dysfunction (6-8). In addition, diltiazem, an agent that lowers glomerular capillary pressure, decreases urinary protein excretion in a manner similar to that of angiotensin-converting enzyme inhibitors in diabetic patients with renal insufficiency and hypertension (9). We conducted a prospective crossover trial to evaluate the effects of diltiazem and nifedipine on urinary protein excretion in diabetic,...References1. Anderson S, Clarey L, Riley S, and Troy J. Acute infusion of calcium channel blockers reduces glomerular capillary pressure in rats with reduced renal mass [Abstract]. Kidney Int. 1988;33:370A. Google Scholar2. Eisenbach G, Van Liew J, and Boylan J. Effect of angiotensin on the filtration of protein in the rat kidney: a micropuncture study. Kidney Int. 1975;8:80-7. CrossrefMedlineGoogle Scholar3. Yoshioka T, Shiraga H, and Yoshida Y. "Intact nephrons" as the primary origin of proteinuria in chronic renal disease. J Clin Invest. 1988;82:1614-23. CrossrefMedlineGoogle Scholar4. Zatz R, Dunn B, Meyer T, Anderson S, Rennke H, and Brenner B. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest. 1986;77:1925-30. CrossrefMedlineGoogle Scholar5. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, and Remuzzi G. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest. 1990;85:541-9. CrossrefMedlineGoogle Scholar6. Mimran A, Insua A, Ribstein J, Monnier L, Bringer J, and Mirouse J. Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. J Hypertens. 1988;6:919-23. CrossrefMedlineGoogle Scholar7. Diamond J, Cheung J, and Fang L. Nifedipine-induced renal dysfunction. Am J Med. 1984;77:905-9. CrossrefMedlineGoogle Scholar8. Dworkin L and Benstein J. Impact of anti-hypertensive therapy on progressive kidney damage. Am J Hypertens. 1989;2:1625-725. CrossrefGoogle Scholar9. Bakris G. Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus. Ann Intern Med. 1990;112:701-2. LinkGoogle Scholar10. Isshiki T, Amodeo C, Messerli F, Pegram B, and Frohlich E. Diltiazem maintains renal vasodilation without hyperfiltration in hypertension: studies in essential hypertensive man and spontaneously hypertensive rat. Cardiovascular Drugs and Therapy. 1987;1:359-66. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: Bryan K. Demarie, MD; George L. Bakris, MDFrom the Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, Louisiana. For current author addresses, see end of text. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byBlood pressure control in type 2 diabetic patientsBlood pressure and antihypertensive medication profile in a multiethnic Asian population of stable chronic kidney disease patientsManaging hypertension in diabetesTreating hypertension in type 2 diabetesAntihypertensive DrugsAntihypertensive Drugs and Their Cardioprotective and Renoprotective Roles in the Prevention and Management of Cardiovascular DiseaseJapan-Indonesia Collaborative Study of Imidapril on Antiproteinuric Effect in Hypertensive Patients with Chronic Kidney Disease (CKD)Effects of Calcium Channel Blockers on Proteinuria in Patients With Diabetic NephropathyHypertensionRenal Protection in Chronic Kidney DiseaseCalcium AntagonistsHypertension management in patients with diabetic nephropathyCalcium antagonistsWhat have we learned from the current trials?Impacto de los fármacos antihipertensivos sobre la enfermedad renalNephroprotective Effect of Bosentan in Diabetic RatsThe evolving role of diltiazem hydrochloride in cardiovascular managementUse of calcium antagonists in renal patients: Therapeutic benefit or medical malpractice?Pharmacologic management of diabetic nephropathyThe choice of antihypertensive drugs in patients with diabetes: Angiotensin II and beyondMicroalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes MellitusType 2 Diabetes: RENAAL and IDNT-The Emergence of New Treatment

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-113-12-987

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Metadata

Authors
Demarie, B. K., & Bakris, G. L.
Venue
Annals of Internal Medicine
Published
1990-12-15
Volume
113
Issue
12
Pages
987-988
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2156663584
Cited by
145
References
0
FWCI
17.32
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Different Calcium Antagonists on Proteinuria Associated with Diabetes Mellitus. https://app.cochat.ai/papers/10.7326/0003-4819-113-12-987
The paper
Demarie, B. K., & Bakris, G. L. (1990). Effects of Different Calcium Antagonists on Proteinuria Associated with Diabetes Mellitus. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-113-12-987

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.